Carotid intima-media thickness: Influence of drug treatment and clinical implications

Netherlands Journal of Medicine

Volumn 55, Issue 4, 1999, Pages 188-195

  Ubels, F L ^a   Terpstra, W F ^a   Smit, A J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Antihypertensive drugs; Atherosclerosis; Carotid artery; IMT; Lipid lowering drugs; Ultrasound

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; AMLODIPINE; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CHLORTALIDONE; COLESTYRAMINE; DIURETIC AGENT; FOSINOPRIL; HYDROCHLOROTHIAZIDE; ISRADIPINE; LACIDIPINE; LISINOPRIL; MEVINOLIN; NIFEDIPINE; PLACEBO; PRAVASTATIN; RAMIPRIL; SIMVASTATIN; VERAPAMIL; WARFARIN;

ANGIOCARDIOGRAPHY; ARTERY INTIMA PROLIFERATION; ARTICLE; BRAIN ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CAROTID ARTERY OBSTRUCTION; HUMAN; HYPERLIPIDEMIA; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MORTALITY; RISK FACTOR;

ANTICHOLESTEREMIC AGENTS; ANTIHYPERTENSIVE AGENTS; CAROTID ARTERIES; CORONARY ARTERIOSCLEROSIS; FEMALE; HUMANS; MALE; PROGNOSIS; SENSITIVITY AND SPECIFICITY; TUNICA INTIMA;

EID: 0032841616     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-2977(99)00053-4     Document Type: Article

References (30)

1. Waters D., Pedersen T.R. Review of cholesterol-lowering therapy: coronary angiographic and events trials. Am J Med. 101:(Suppl 4A):1996;34S-39S.
2. Blankenhorn D.H., Selzer R.H., Crawford D.W., et al. Beneficial effects of colestipol-niacin therapy on the common carotid artery. Two- and four-year reduction of intima-media thickness measured by ultrasound. Circulation. 88:1993;20-28.
3. Furberg C.D., Adams H.P. Jr., Applegate W.B., et al. Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group. Circulation. 90:(4):1994;1679-1687.
4. Crouse J.R., Byington R.P., Bond M.G., et al. Pravastatin, lipids and atherosclerosis in the carotid arteries (PLAC-II). Am J Cardiol. 75:1995;455-459.
5. Salonen R., Nyyssönen K., Porkkala E., et al. Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries. Circulation. 92:1995;1758-1764.
6. Hodis H.N., Mack W.J., LaBree L., et al. Reduction in carotid arterial wall thickness using lovastatin and dietary therapy. A randomized, controlled clinical trial. Ann Intern Med. 124:1996;548-556.
7. Mercuri M., Bond M.G., Sirtori C.R., et al. Pravastatin reduces carotid intima-media thickness progression in an asymptomatic hypercholesterolemic mediterranean population: the Carotid Atherosclerosis Italian Ultrasound Study. Am J Med. 101:1996;627-634.
8. MacMahon S., Sharpe N., Gamble G., et al. Effects of lowering average or below-average cholesterol levels on the progression of carotid atherosclerosis. Results of the LIPID Atherosclerosis Substudy. Circulation. 97:1998;1784-1790.
9. De Groot E., Jukema J.W., Montauban A.D., et al. B-Mode ultrasound assessment of pravastatin treatment effect on carotid and femoral artery walls and its correlations with coronary arteriographic findings: a report of the Regression Growth Evaluation Statin Study. J Am Coll Cardiol. 31:1998;1561-1567.
10. Smit A.J. Non-invasive imaging of the arterial wall: new perspectives on atherosclerosis? Neth J Med. 46:1995;117-122.
11. Bonithon-Kopp C. Prevalence of and risk factors for intima-media thickening: a literature review. Touboul P.-J., Crouse III J.R. Intima-media thickness and atherosclerosis. Predicting the risk? 1997;27-44 Parthenon Publishing Group, New York.
12. O'Leary D.H., Polak J.F., Kronmal R.A., Manolio T.A., Burke G.L., Wolfson S.K. Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. New Engl J Med. 340:1999;14-22.
13. Crouse J.R., Byington R.P., Bond M.G., et al. Pravastatin, lipids and atherosclerosis in the carotid arteries: design features of a clinical trial with carotid atherosclerosis outcome. Control. Clin Trials. 13:1992;495-506.
14. Salonen J.T., Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb. 11:1991;1245-1249.
15. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. New Engl J Med. 339:1998;1349-1357.
16. Hodis H.N., Mack W.J., Dunn M., et al. Intermediate-density lipoproteins and progression of carotid arterial wall intima-media thickness. Circulation. 95:1997;2022-2026.
17. O'Leary D.H., Polak J.F., Wolfson S.K. Jr., et al. Use of sonography to evaluate carotid atherosclerosis in the elderly. The Cardiovascular Health Study. Stroke. 22:1991;1155-1163.
18. Crouse III J.R., Craven T.E., Hagaman A.P., Bond M.G. Association of coronary disease with segment-specific intimal-medial thickening of the extracranial carotid artery. Circulation. 92:1995;1141-1147.
19. Mack W.J., Selzer R.H., Hodis N.H., et al. One-year reduction and longitudinal analysis of carotid intima-media thickness associated with colestipol/niacin therapy. Stroke. 24:1993;1779-1783.
20. Crouse III J.R. Associations of arterial wall thickening and coronary disease. Touboul P.-J., Crouse J.R. III. Intima-media thickness and atherosclerosis. Predicting the risk? 1997;105-115 Parthenon Publishing Group, New York.
21. Bots M.L., Hoes A.W., Koudstaal P.J., Hofman A., Grobbee D.E. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation. 96:1997;1432-1437.
22. Chambless L.E., Heiss G., Folsom A.R., et al. Association of coronary heart disease incidence with carotid arterial wall thickness and the major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol. 146:1997;483-494.
23. Hodis H.N., Mack W.J., LaBree L., et al. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med. 128:1998;262-269.
24. Borhani N.O., Mercuri M., Borhani P.A., et al. Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). J Am Med Assoc. 276:1996;785-791.
25. Zanchetti A., AgabitiRosei E., DalPalù C., Leonetti G., Magnani B., Pessina A. The Verapamil in Hypertension and Atherosclerosis Study (VHAS): results of long-term randomized treatment with either verapamil or chlorthalidone on carotid intima-media thickness. J Hypertens. 16:1998;1667-1676.
26. Persson J., Israelsson B., Stavenow L., Holmstrom E., Berglund G. Progression of atherosclerosis in middle-aged men: effects of multifactorial intervention. J Intern Med. 239:1996;425-433.
27. Zanchetti A. Antiatherosclerotic effects of antihypertensive drugs: recent evidence and ongoing trials. Clin Exp Hypertens. 18:(3-4):1996;489-499.
28. Ludwig M., Stumpe K.O., Heagerty A.M., et al. Vascular wall thickness in hypertension: the Perindopril Regression Of vascular Thickening European Community Trial (PROTECT). J Hypertens. 11:(Suppl 5):1993;S316-S317.
29. Lonn E.M., Yusuf S., Doris C.I., et al. Study design and baseline characteristics of the Study to Evaluate Carotid Ultrasound changes in patients treated with Ramipril and vitamin E. Am J Cardiol. 78:1996;914-919.
30. Howard G., Sharrett A.R., Heiss G., et al. Carotid artery intimal-medial thickness distribution in general populations as evaluated by B-mode ultrasound. Stroke. 24:1993;1297-1304.